| Role |
Name |
Disclosure |
Details |
| Author | Annie Chiu, MD, Staff Physician, Department of Dermatology, Cedars-Sinai Medical Group | Nothing to disclose | Details | | Coauthor | Alexa F Boer Kimball, MD, MPH, Associate Professor of Dermatology, Harvard University School of Medicine; Director of Clinical Unit for Research Trials in Skin, Associate Dermatologist, Department of Dermatology, Massachusetts General and Brigham and Women's Hospitals | Nothing to disclose | Details | | Medical Editor | Peter Fritsch, MD, Chair, Department of Dermatology and Venereology, University of Innsbruck, Austria | Nothing to disclose | Details | | Pharmacy Editor | David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Director, Division of Dermatology, Scott and White Clinic; Director Dermatology Residency Training Program, Scott and White Clinic | 3M Pharmaceutical Graceway Pharmaceuticals | Details | | Managing Editor | Jeffrey Meffert, MD, Assistant Clinical Professor of Dermatology, University of Texas Health Science Center-San Antonio | Nothing to disclose | Details | | CME Editor | Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University | Nothing to disclose | Details | | Chief Editor | Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Peter Fritsch, Medical Editor |
The contributor discloses no conflict of interest. |
|